First in Man Oral
and Parenteral Dosage Forms
SEE ARTICLE
Early-Stage, IND-Enabling Formulations
for PK & Toxicoloxy Studies
SEE ARTICLE
Rapid Development Through
Phase I Clinical Trial Materials
SEE ARTICLE
Formulations for Poorly Soluble
& Low Bioavailability Drugs
SEE ARTICLE
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL
Our Technologies
A wide array of pharmaceutical development capabilities for manufacturing and analyzing drug product dosage forms. READ MORE >
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
SEE ARTICLEPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM

One of the biggest challenges within our industry today has to do with new molecules – roughly 90% of drugs coming out of discover […]
READ MORE >
Savills represented Ascendia Pharmaceuticals (Ascendia) in a multi-year lease restructure and expansion, resulting in the specialt […]
READ MORE >
DCAT (the Drug, Chemical, and Associated Technologies Association) will hold its annual event, commonly known as DCAT Week, March […]
READ MORE >
Want to learn more about
Ascendia's expertise?
Get up-to-date information